Cytokines as a common components of two different disorders: Metabolic syndrome and hemophagocytic lymphohystiositosis

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 2, 2009, Pages 57-59

  Siklar Z ^a,b   Berberoglu M ^a   Uysal, Z ^a   Ctak F E ^a   Bilir, P ^a   Ertem, M ^a   Engiz, O ^a   Ocal G ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Cytokines; Metabolic syndrome; Obesity

Indexed keywords

CYTOKINE;

ABDOMINAL OBESITY; ARTICLE; CASE REPORT; CHILD; COMORBIDITY; CYTOKINE RELEASE; DYSLIPIDEMIA; FEMALE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MACROPHAGE ACTIVATION; METABOLIC SYNDROME X; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN FUNCTION;

CHILD; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC DISEASES; METABOLIC SYNDROME X; PHAGOCYTOSIS;

EID: 61849084754     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-2008-1076717     Document Type: Article

References (22)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med 1998; 15: 539-553
2. Arico M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, Martinetti M, Rusca MP. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 1996 Feb; 10 (2): 197-203
3. Atabek ME, Pirgon Ö, Kurtoglu S. Prevalence of metabolic syndrome in obese Turkish children and adolescents. Diab Res Clin Prac 2006; 72 (3):315-321
4. Berghe G, Zegher F, Bouillon R. Acute and Prolonged Critical Illness as Different Neuroendocrine Paradigms. JCEM 1998; 83 (6): 1827-1834
5. Biliau AD, Roskams T, Damme-Lombaerts R Van, Matthys P, Wounters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN γ-producing lymphocytes and IL-6 and TNF α producing macrophages. Blood 2005; 105 (4):1648-1651
6. Bitsori M, Kafatos A. Dysmetabolic syndrome in childhood and adolescence. Acta Pædiatrica 2005; 94: 995-1005
7. Chopra IJ, Huang TS, Beredo A, Solomon DH, Chua Teco GN, Mead JF. Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,39- triiodothyronine in sera of patients with non-thyroidal illness. J Clin Endocrinol Metab 1985;60:666- 672
8. Coppack SW. Fat cells and cytokines. Topical Endocrinol 2004; 24: 13-16
9. Fronzo RA De. Insulin resistance syndrome. Diabetes Care 1991; 14: 173-194
10. Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Jane W. Prevalence of the metabolic syndrome in American adolescents findings from the Third National Health and Nutrition Examination Survey. Circulation 2004;110:2494-2497
11. Henter JI, Horne AC, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, MacClain K, Webb D, Winiarski J, Janka R. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131
12. Hristova M, Aloe L. Metabolic syndrome-neurotrophic hypothesis. Med Hypothes 2006; 66:545-549
13. Grimble RF. Inflammatory status and insuln resistance. Curr Opin Clin Nutr Metab Care 2002;5:551-559
14. Kakucska I, Romero LI, Clark BD, Rondeel JM, Alex S, Emerson CH, Lechan RM. Suppression of thyrotropin-releasing hormone gene expression by interleukin-1-beta in the rat: implications for nonthyroidal illness. Neuroendocrinology 1994; 59:129-137
15. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmunity Reviews 2004; 3:69-75
16. Matsuzawa Y. The metabolic syndrome and adipokines. FEBS Lett 2006; 580 (12):2917- 2921
17. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and metabolic perspective. Annu Rev med 2004;56:45-62
18. Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final Report. Bethesda, Md: National Heart, Lung, and Blood Institute 2002; http://www.nhlbi.nih.gov/guidelines/cholesterol/ atp3full.pdf
19. Shintani F, Nakaki T, Kanba S, Kato R, Asai M. Role of interleukin-1 in stress responses. A putative neurotransmitter. Mol Neurobiol 1995;10 (1): 47-71
20. Stouthard JML, Poll T van der, Endert E. Effects of acute and chronic interleukin-6 administration on the thyroid hormone metabolism in humans. J Clin Endocrinol Metab 1994; 79: 1342-1346
21. Tomlinson JW, Stewart PM. Cortisol metabolism and the role of 11betahydroxysteroid dehydrogenase. Best Pract Res Clin Endocrinol Metab 2001; 15: 61-78
22. Wartofski L, Burman KD. Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". Endocr Rev 1982;3:164-167